142 related articles for article (PubMed ID: 26566652)
1. Outcome of patients with malignant glioma and synchronous or metachronous non-central nervous system primary neoplasms.
Hamza MA; Kamiya-Matsuoka C; Liu D; Yuan Y; Puduvalli VK
J Neurooncol; 2016 Feb; 126(3):527-33. PubMed ID: 26566652
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas.
McKenzie JT; Guarnaschelli JN; Vagal AS; Warnick RE; Breneman JC
J Neurooncol; 2013 Jul; 113(3):403-9. PubMed ID: 23589034
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.
Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV
J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.
Reardon DA; Quinn JA; Rich JN; Desjardins A; Vredenburgh J; Gururangan S; Sathornsumetee S; Badruddoja M; McLendon R; Provenzale J; Herndon JE; Dowell JM; Burkart JL; Newton HB; Friedman AH; Friedman HS
Cancer; 2005 Oct; 104(7):1478-86. PubMed ID: 16088964
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.
Wen PY; Chang SM; Lamborn KR; Kuhn JG; Norden AD; Cloughesy TF; Robins HI; Lieberman FS; Gilbert MR; Mehta MP; Drappatz J; Groves MD; Santagata S; Ligon AH; Yung WK; Wright JJ; Dancey J; Aldape KD; Prados MD; Ligon KL
Neuro Oncol; 2014 Apr; 16(4):567-78. PubMed ID: 24470557
[TBL] [Abstract][Full Text] [Related]
6. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.
Hickmann AK; Nadji-Ohl M; Hopf NJ
J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.
Würschmidt F; Bünemann H; Heilmann HP
Strahlenther Onkol; 1995 Jun; 171(6):315-21. PubMed ID: 7597616
[TBL] [Abstract][Full Text] [Related]
9. Models of epigenetic age capture patterns of DNA methylation in glioma associated with molecular subtype, survival, and recurrence.
Liao P; Ostrom QT; Stetson L; Barnholtz-Sloan JS
Neuro Oncol; 2018 Jun; 20(7):942-953. PubMed ID: 29432558
[TBL] [Abstract][Full Text] [Related]
10. Persistent outpatient hyperglycemia is independently associated with survival, recurrence and malignant degeneration following surgery for hemispheric low grade gliomas.
Chaichana KL; McGirt MJ; Woodworth GF; Datoo G; Tamargo RJ; Weingart J; Olivi A; Brem H; Quinones-Hinojosa A
Neurol Res; 2010 May; 32(4):442-8. PubMed ID: 19589201
[TBL] [Abstract][Full Text] [Related]
11. Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
Krishnatry R; Zhukova N; Guerreiro Stucklin AS; Pole JD; Mistry M; Fried I; Ramaswamy V; Bartels U; Huang A; Laperriere N; Dirks P; Nathan PC; Greenberg M; Malkin D; Hawkins C; Bandopadhayay P; Kieran MW; Manley PE; Bouffet E; Tabori U
Cancer; 2016 Apr; 122(8):1261-9. PubMed ID: 26970559
[TBL] [Abstract][Full Text] [Related]
12. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
[TBL] [Abstract][Full Text] [Related]
13. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance.
Claus EB; Horlacher A; Hsu L; Schwartz RB; Dello-Iacono D; Talos F; Jolesz FA; Black PM
Cancer; 2005 Mar; 103(6):1227-33. PubMed ID: 15690327
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients.
Ahmadi R; Dictus C; Hartmann C; Zürn O; Edler L; Hartmann M; Combs S; Herold-Mende C; Wirtz CR; Unterberg A
Acta Neurochir (Wien); 2009 Nov; 151(11):1359-65. PubMed ID: 19575144
[TBL] [Abstract][Full Text] [Related]
15. Treatment by specialist surgical neurooncologists improves survival times for patients with malignant glioma.
Khan UA; Bhavsar A; Asif H; Karabatsou K; Leggate JR; Sofat A; Kamaly-Asl ID
J Neurosurg; 2015 Feb; 122(2):297-302. PubMed ID: 25415070
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of single-agent bevacizumab in Japanese patients with recurrent malignant glioma.
Nagane M; Nishikawa R; Narita Y; Kobayashi H; Takano S; Shinoura N; Aoki T; Sugiyama K; Kuratsu J; Muragaki Y; Sawamura Y; Matsutani M
Jpn J Clin Oncol; 2012 Oct; 42(10):887-95. PubMed ID: 22844129
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment and survival outcome of patients with adult thalamic glioma: a single institution experience of 8 years.
Niu X; Wang T; Zhou X; Yang Y; Wang X; Zhang H; Chen N; Yue Q; Wang F; Zhang Y; Liu Y; Mao Q
J Neurooncol; 2020 Apr; 147(2):377-386. PubMed ID: 32157551
[TBL] [Abstract][Full Text] [Related]
18. Outcome of discontinuing bevacizumab prior to malignant glioma progression.
Sherman WJ; Raizer JJ; Grimm SA
J Neurooncol; 2013 Jan; 111(1):87-9. PubMed ID: 23065093
[No Abstract] [Full Text] [Related]
19. Temozolomide in the treatment of recurrent malignant glioma in Chinese patients.
Chan DT; Poon WS; Chan YL; Ng HK
Hong Kong Med J; 2005 Dec; 11(6):452-6. PubMed ID: 16340021
[TBL] [Abstract][Full Text] [Related]
20. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
